查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2017522

急性復健市場：按服務類型、疾病類型、階段、設備類型、患者年齡層、提供者類型和最終用戶分類 - 全球市場預測（2026-2030 年）

Acute Rehabilitation Market by Service Type, Disease Type, Phase Type, Device Type, Patient Age Group, Provider Type, End User - Global Forecast 2026-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年急性復健市場價值 551 億美元，預計到 2025 年將成長至 592.1 億美元，複合年成長率為 7.66%，到 ​​2030 年將達到 858.2 億美元。

主要市場統計數據
基準年（2024 年） 551億美元
預計年份（2025年） 592.1億美元
預測年份（2030 年） 858.2億美元
複合年成長率 (%) 7.66%

隨著護理模式的轉變和對綜合性復健後解決方案的需求增加，急性復健領域的創新正在奠定基礎。

近年來，急性復健領域已成為連結患者出院與長期功能恢復的關鍵橋樑。心臟病、神經損傷、整形外科手術或慢性肺病患者越來越依賴系統性的復健計畫來恢復運動功能、認知功能和整體生活品質。這種依賴性的增強源於人口結構的變化，例如人口老化導致對急性後期護理服務的需求不斷成長，以及技術進步使得對患者康復進展的評估和監測更加精準。同時，醫療保險公司和醫療服務提供者也逐漸認知到早期療育策略的價值，這些策略有助於降低再入院率和整體醫療成本。因此，急性復健計劃正在超越傳統的治療模式，融入數據驅動和以患者為中心的理念。

探索變革性變化，透過技術整合、支付系統改革和以患者為中心的卓越護理，重塑急性復原。

技術創新一直是推動急性復健轉型發展的指路明燈。利用人工智慧 (AI) 和機器學習的平台能夠預測患者病情進展，並在併發症出現之前發出預警，從而補充臨床醫生的專業技能。穿戴式裝置和遠端監測工具將照護延伸至患者的家庭環境，有助於提高治療依從性，並實現治療方案的即時調整。隨著這些數位化方法的日趨成熟，電子健康記錄 (EHR) 和復健管理系統之間的互通性變得至關重要，它能夠促進無縫資料交換，並推動更全面的醫療協作。

評估 2025 年美國關稅對急性復健供應鏈、服務提供和成本結構的累積影響。

2025年起實施的新關稅將影響到種類繁多的進口復健設備和器械，並對供應鏈和成本結構產生連鎖反應。製造商面臨機器人、助行器和物理治療設備等關鍵零件進口關稅上漲的困境。這些課稅促使一些供應商加快在地化策略，例如尋找國內供應商並簽訂聯合生產協議，以緩解成本壓力並確保供應的連續性。

從服務、疾病、治療階段、設備類型、年齡層、提供者和最終用戶的觀點，闡明急性復健的深入細分。

依服務類型分析，急性復健體系呈現片段化但又相互依存的模式。心臟復健項目，包括心血管手術後治療和心肌梗塞後康復，與專注於步態訓練、平衡功能恢復和肌肉力量訓練的門診物理治療服務緊密結合。神經復健涵蓋中風和創傷性腦損傷的治療路徑，運用職業治療技術和先進的機器人設備來增強神經可塑性。此外，整形外科復健、呼吸治療和言語治療也對這套系統進行補充，確保了護理的無縫銜接。

為了闡明影響北美和南美、歐洲、中東和非洲以及亞太地區醫療保健環境中急性復原的主要區域趨勢。

在美洲，急性復健的特點是公立和私立醫療體系高度融合，主要醫療機構大力投資先進的機器人設備和遠端醫療平台。美國的醫療政策改革正在推動基於價值的支付模式的普及，並鼓勵早期活動和多學科醫療團隊的組成。在拉丁美洲，數位化普及速度較慢，但居家復健服務正在逐步擴展，以彌合地理上的差距。

介紹引領急性復健未來發展的主要企業透過創新、策略合作和不斷擴展的服務組合，塑造著急性康復的未來。

急性復健領域的領先機構正透過策略性研發投資和合作夥伴關係推動創新。主要醫療設備製造商正專注於開發可適應不同治療方法的模組化機器人平台。同時，專注於遠端醫療的科技公司正與復健機構合作，提供遠端監測和虛擬指導解決方案。

為行業領導者提供實用建議，以利用急性復健趨勢並在急性後期護理中保持競爭優勢。

醫療機構應優先採用擴充性的數位化平台，以實現即時數據分析，從而衡量遠距病人參與和功能改善。這種方法不僅能加強護理協調，還能提升以價值為導向的醫療提案，並將臨床結果與薪酬獎勵掛鉤。投資人才培育計畫有助於解決治療師短缺問題，並培養能夠有效利用新興技術的跨學科團隊。

詳細介紹了在急性復健分析中，為發現見解、確保資料完整性和檢驗結果而採用的嚴格調查方法。

本分析基於一套嚴謹的研究框架，結合了第一手和第二手調查方法。第一手調查包括對高階主管、臨床主任和復健專家進行深入訪談，以收集有關新興挑戰和創新促進因素的定性見解。此外，也針對支付者和醫療機構發放了問卷，以了解報銷趨勢和對技術採納的看法，從而補充了上述調查結果。

整合關鍵結論，突顯急性復健領域相關人員面臨的策略挑戰和未來方向。

急性復健領域正處於一個轉折點，技術進步、政策改革和不斷變化的患者預計在此交匯融合。能夠有效整合數位化健康解決方案與個人化、多學科照護模式的機構，將能夠改善臨床療效並獲得有利的報銷條件。地域和人口細分為最佳化服務組合提供了途徑，而區域特徵則凸顯了根據當地法規和經濟狀況制定適應性策略的重要性。

目錄

第1章 引言

第2章 分析方法

  • 分析設計
  • 分析框架
  • 市場規模預測
  • 數據三角測量
  • 分析結果
  • 分析的前提條件
  • 分析的局限性

第3章執行摘要

  • 首席體驗長的觀點
  • 市場規模和成長趨勢
  • 市佔率分析（2025 年）
  • FPNV定位矩陣（2025）
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入（GTM）策略

第5章 市場洞察

  • 消費者分析與最終用戶觀點
  • 消費者體驗基準測試
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 成本效益分析（ROI）和成本效益分析（CBA）

第6章：美國關稅的累積影響（2025 年）

第7章：人工智慧（AI）的累積影響（2025 年）

第8章 急性復健市場：依服務類型分類

  • 心臟復健
    • 心血管手術後的康復
    • 心肌梗塞後的康復
  • 神經復健
    • 中風復健
    • 創傷性腦損傷康復
  • 職業療法
  • 整形外科復健
  • 物理治療
    • 平衡與協調療法
    • 移動訓練
    • 肌力和耐力訓練
  • 呼吸復健
  • 語言治療

第9章 急性復健市場：依疾病類型分類

  • 心律不整
  • 心絞痛
  • 心房顫動
  • 膽固醇管理
  • 冠狀動脈繞道術
  • 冠狀動脈/周邊動脈疾病
  • 糖尿病
  • 心臟衰竭/心臟移植
  • 高血壓
  • 肺動脈高壓

第10章：急性復健市場：依階段分類

  • 第一階段（急性期）
  • 第二階段（亞急性期）
  • 第三階段（長期）
  • 第四階段（社會重返）

第11章 急性復健市場：依設備類型分類

  • 認知和語言支援設備
  • 行動輔助設備
  • 監控工具
  • 物理治療設備
  • 機器人設備

第12章 急性復健市場：依患者年齡層別分類

  • 成人
  • 老年人
  • 兒童

第13章 急性復健市場：依服務提供者類型分類

  • 居家康復
  • 醫院
  • 住院急性護理復健中心
  • 門診復健

第14章 急性復健市場：依最終用戶分類

  • 政府和公共衛生機構
  • 醫療保健提供者
  • 病人

第15章：急性復健市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 急性復健市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 急性復健市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國急性復健市場

第19章：中國急性復健市場

第20章 競爭格局

  • 市場集中度分析（2025 年）
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析（2025 年）
  • 產品系列分析（2025 年）
  • 基準分析（2025 年）
  • Acadia Healthcare Company, Inc.
  • Amedisys, Inc.
  • Athena Health Care Systems
  • Aurora Behavioral Health System
  • Cambridge Medical and Rehabilitation Center
  • CareOne Management, LLC by New Frontier Energy, Inc.
  • ClearSky Health
  • Covenant Care
  • Ekso Bionics Holdings, Inc.
  • Encompass Health Corporation
  • Five Star Senior Living by AlerisLife Inc.
  • Genesis Healthcare, Inc.
  • HCA Healthcare, Inc.
  • LHC Group, Inc. by UnitedHealth Group Incorporated
  • LifePoint Health, Inc.
  • National Healthcare Corporation
  • Nexion Health, Inc.
  • Oceans Healthcare
  • Paradigm Healthcare
  • Promises Behavioral Health, LLC
  • Select Medical Corporation
  • St. Ann's Community
  • Tenet Healthcare Corporation
  • The Alden Network
  • The Ensign Group, Inc.
  • Universal Health Services Inc.
Product Code: MRR-0376B2CAB000

The Acute Rehabilitation Market was valued at USD 55.10 billion in 2024 and is projected to grow to USD 59.21 billion in 2025, with a CAGR of 7.66%, reaching USD 85.82 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 55.10 billion
Estimated Year [2025] USD 59.21 billion
Forecast Year [2030] USD 85.82 billion
CAGR (%) 7.66%

Setting the Stage for Acute Rehabilitation Innovation Amid Evolving Care Paradigms and Growing Demand for Integrated Post-Acute Solutions

In recent years, the acute rehabilitation sector has emerged as a critical nexus between hospital discharge and long-term functional recovery. Patients facing cardiac events, neurological injuries, orthopedic procedures, or chronic pulmonary conditions increasingly rely on structured programs to restore mobility, cognitive function, and overall quality of life. This growing reliance has been fueled by demographic shifts, with an aging population driving demand for post-acute services, and technological advances that enable more precise assessment and monitoring of patient progress. In parallel, healthcare payers and providers have recognized the value of early intervention strategies to reduce readmission rates and lower total cost of care. Consequently, acute rehabilitation programs are evolving beyond traditional therapy models to embrace data-driven, patient-centered approaches.

More than ever, the acute rehabilitation landscape is being redefined by the convergence of clinical best practices and digital health innovations. Real-time telemonitoring, wearable sensors, and remote therapy platforms are extending the reach of interventions beyond hospital walls, facilitating continuity of care and enhancing patient engagement. This transformation is further supported by a shift in reimbursement policies that reward outcomes and value-based care, prompting providers to invest in integrated service lines and multidisciplinary teams. Such a holistic approach not only addresses physical impairments but also emphasizes psychosocial support, caregiver education, and home environment modifications to optimize recovery trajectories.

Despite these promising trends, the acute rehabilitation ecosystem faces significant challenges. Variability in care standards, limited access in rural or underserved areas, and resource constraints in post-acute facilities can impede timely initiation of therapy. Providers must also contend with workforce shortages, as the demand for specialized therapists outpaces available training programs. Payers are scrutinizing cost drivers and emphasizing care coordination, introducing performance benchmarks that necessitate robust data analytics capabilities. Simultaneously, patients and caregivers are demanding greater transparency, seamless communication, and personalized care plans that reflect individual goals and lifestyles.

In this executive summary, we embark on an in-depth exploration of the acute rehabilitation sector, examining transformative shifts, policy impacts, segmentation dynamics, regional nuances, and leading industry players. By synthesizing actionable insights and outlining methodological rigor, this report aims to equip stakeholders with a comprehensive understanding of the operating environment and strategic levers for value creation. The subsequent sections will illuminate critical trends, dissect tariff implications, and offer tailored recommendations to drive innovation, enhance patient outcomes, and foster sustainable growth in the evolving acute rehabilitation landscape.

Exploring Transformative Shifts Reshaping Acute Rehabilitation through Technological Integration, Payment Reforms and Patient-Centric Care Excellence

Technological innovation has been the lodestar guiding the transformation of acute rehabilitation. Platforms leveraging artificial intelligence and machine learning are now augmenting clinician expertise by delivering predictive insights into patient progress, flagging risks of complications before they emerge. Wearable devices and remote monitoring tools have extended therapeutic engagement into the patient's home environment, fostering adherence and enabling real-time adjustments to therapy plans. As these digital modalities mature, interoperability across electronic health records and rehabilitation management systems is becoming paramount, facilitating seamless data exchange and fostering more holistic care coordination.

Payment reforms and evolving reimbursement landscapes represent another pivotal shift. Traditional fee-for-service models are increasingly supplanted by value-based arrangements that reward measurable outcomes and penalize avoidable readmissions. This paradigm incentivizes providers to streamline care pathways, optimize resource allocation, and demonstrate efficacy through quantifiable metrics. Early adopters of bundled payment systems and accountable care contracts are already witnessing reductions in overall episode costs while preserving or enhancing patient functional gains.

Concurrently, there has been a decisive move toward patient-centric care excellence. The integration of behavioral health support, caregiver education, and community reintegration planning has broadened the scope of acute rehabilitation beyond pure physical therapy. Collaborative care models now incorporate social determinants of health assessments to tailor interventions that address factors such as housing stability, nutrition, and mental well-being. This holistic construct not only expedites recovery but also mitigates the risk of secondary complications.

Finally, strategic partnerships and consolidation trends are reshaping the competitive landscape. Healthcare systems, specialized rehabilitation providers, and technology vendors are forging alliances to deliver end-to-end solutions. These collaborations aim to combine clinical expertise with digital health platforms, creating ecosystems that support seamless transitions of care. As the sector continues to evolve, stakeholders who can align these multifaceted shifts into cohesive strategies will secure leadership positions in the acute rehabilitation market.

Assessing the Cumulative Impact of United States Tariffs in 2025 on Acute Rehabilitation Supply Chains, Service Delivery and Cost Structures

The introduction of new tariffs in 2025 affecting a range of imported rehabilitation equipment and devices has reverberated across supply chains and cost structures. Manufacturers have faced import duty increases on critical components used in robotics, mobility aids, and physiotherapy equipment. These levies have prompted some providers to accelerate localization strategies, seeking domestic suppliers or entering co-manufacturing agreements to mitigate cost pressures and ensure supply continuity.

Service delivery models have also adapted in response to tariff-driven cost escalations. Providers are exploring alternative sourcing channels and bulk procurement arrangements to spread financial burdens. In certain regions, acute rehabilitation operators have adjusted pricing models, rebalancing between bundled service fees and itemized billing for specialized equipment usage. These adjustments necessitate transparent communication with payers to sustain reimbursement rates aligned with rising input costs.

Moreover, the tariffs have influenced technology adoption timelines. Investments in advanced monitoring tools and robotic devices have been deferred or phased, as stakeholders reevaluate return-on-investment metrics under the new cost paradigm. Simultaneously, there has been renewed interest in lower-cost digital solutions, such as app-based rehabilitation programs and remote coaching platforms, offering more scalable deployment in a tariff-impacted market.

While these shifts have generated short-term financial strain, they have also catalyzed innovation. Collaboration between device manufacturers and rehabilitation providers has intensified to develop modular equipment that can be assembled or upgraded locally. This modularity reduces import dependencies and enhances customization to meet specific patient population needs. As the sector navigates these tariff influences, resilience and agility in supply chain management and strategic procurement practices will be pivotal to sustaining growth and preserving quality of care.

Revealing Insightful Segmentation of Acute Rehabilitation by Service, Disease, Treatment Phases, Device Types, Age Groups, Provider and End User Perspectives

Analysis by service type reveals a fragmented yet interdependent acute rehabilitation ecosystem. Cardiac rehabilitation programs, encompassing post-cardiac surgery therapy and post-heart attack recovery, are tightly integrated with outpatient physical therapy services that focus on mobility training, balance restoration, and strength conditioning. Neurological rehabilitation initiatives, comprising stroke and traumatic brain injury pathways, leverage both occupational therapy techniques and advanced robotic devices to enhance neural plasticity. Orthopedic rehabilitation, pulmonary therapy, and speech and language interventions further complement this matrix, enabling a seamless continuum of care.

When viewed through the lens of disease type, the acute rehabilitation market addresses conditions ranging from abnormal heart rhythms and atrial fibrillation to coronary artery bypass surgery aftercare. Management of high blood pressure and pulmonary hypertension often overlaps with diabetes education and heart failure transplant coordination, resulting in multidisciplinary programs that span clinical boundaries. By aligning therapeutic regimens with specific disease profiles, providers can deliver more personalized interventions that accelerate recovery while reducing resource duplication.

Phase-based segmentation underscores the evolving needs of patients. The acute or Phase I setting prioritizes stabilization and early mobilization immediately post-injury or surgery. Phase II transitions to sub-acute facilities or outpatient centers, focusing on progressive strength and endurance training. Phase III long-term care emphasizes community reintegration, while Phase IV targets full social and vocational return, often utilizing remote monitoring tools and telehealth touchpoints to sustain engagement.

Device type perspectives highlight the critical role of equipment in optimizing therapeutic outcomes. Cognitive and speech devices support neurological patients, whereas mobility devices and robotic platforms empower orthopedic and cardiac cohorts. Monitoring tools and physiotherapy equipment provide real-time feedback, enabling therapists to adjust interventions dynamically. This convergence of hardware underpins the precision of modern rehabilitation programs.

Patient demographics and provider formats further delineate service delivery. Adult, geriatric, and pediatric populations each present unique rehabilitation trajectories, prompting providers to tailor protocols accordingly. Settings range from home-based rehabilitation to hospitals, inpatient acute rehabilitation centers, and outpatient clinics, each offering distinct advantages in terms of intensity, accessibility, and cost structure. Finally, end users-spanning government and public health agencies, healthcare institutions, and directly engaged patients-interact with these segmented offerings to align clinical goals with budgetary and policy imperatives.

Illuminating Key Regional Dynamics Impacting Acute Rehabilitation across the Americas, Europe Middle East Africa and Asia Pacific Healthcare Landscapes

Across the Americas, acute rehabilitation is characterized by robust integration of private and public healthcare systems, where leading providers heavily invest in advanced robotic devices and telehealth platforms. Health policy reforms in the United States have driven adoption of value-based payment schemes, incentivizing early mobilization and multidisciplinary care teams. Latin America, while experiencing slower digital penetration, is progressively expanding home-based rehabilitation services to address geographic disparities.

In Europe, the Middle East and Africa region, established healthcare infrastructures in Western Europe showcase comprehensive post-acute networks supported by government reimbursement models. Central and Eastern European markets are witnessing gradual uptake of mobile monitoring tools as regulatory frameworks evolve. In the Middle East and Africa, public-private partnerships are emerging to fund rehabilitation centers that bridge urban-rural gaps, with an emphasis on tackling noncommunicable disease burdens.

The Asia-Pacific landscape is defined by rapid technological adoption and substantial investments in healthcare modernization. Countries like Japan and South Korea lead in integrating robotics and virtual reality therapies into acute settings, whereas India and Southeast Asia are scaling outpatient and home-based services to meet surging demand. Regulatory harmonization efforts and international collaborations are facilitating faster device approvals, fostering market expansion and cross-border knowledge exchange.

Profiling Leading Players Shaping the Future of Acute Rehabilitation through Innovation, Strategic Partnerships and Expanding Service Portfolios

Leading organizations in the acute rehabilitation space are driving innovation through strategic research and development investments and collaborative partnerships. Major medical device manufacturers are focusing on modular robotic platforms that can be adapted for diverse therapy modalities. Simultaneously, technology firms specializing in telehealth are aligning with rehabilitation providers to deliver remote monitoring and virtual coaching solutions.

Several global healthcare systems and specialty chains are optimizing their delivery networks by integrating inpatient, outpatient, and home-based rehabilitation under unified management structures. These vertically aligned models facilitate standardized protocols, centralized data analytics, and consistent quality measures. In parallel, smaller boutique providers are differentiating through niche offerings, such as pediatric neurological rehabilitation programs and geriatric balance training clinics that leverage culturally tailored interventions.

Strategic alliances between device innovators, software developers, and clinical centers of excellence are accelerating the translation of cutting-edge research into practical applications. Joint ventures are increasingly focused on spanning the full continuum of care, from acute phase stabilization to community reintegration, ensuring that patients benefit from seamless transitions and coherent treatment pathways. As competitive pressures intensify, organizations that can harness these collaborative networks to deliver integrated, outcome-driven solutions are poised to outperform in the acute rehabilitation market.

Delivering Actionable Recommendations for Industry Leaders to Capitalize on Acute Rehabilitation Trends and Sustain Competitive Advantage in Post-Acute Care

Providers should prioritize the adoption of scalable digital platforms that enable remote patient engagement and real-time data analytics to measure functional gains. This approach will not only enhance care coordination but also strengthen value-based care propositions, aligning clinical results with reimbursement incentives. Investing in workforce development programs will address therapist shortages and cultivate cross-disciplinary teams capable of deploying emerging technologies effectively.

Supply chain resilience can be fortified by establishing strategic partnerships with domestic component manufacturers and exploring modular equipment designs that reduce import dependencies. Such initiatives will mitigate the financial impacts of tariff fluctuations and ensure continuity of service delivery. Concurrently, negotiating volume-based procurement contracts with device vendors will leverage economies of scale and secure favorable pricing.

To capture regional growth opportunities, organizations should tailor service offerings to local regulatory environments and reimbursement structures. In emerging markets, expanding home-based rehabilitation networks through telehealth and mobile clinics can overcome geographic barriers. In developed markets, deepening integration across acute, sub-acute, and long-term care phases will drive differentiation and foster patient loyalty.

Finally, leaders must cultivate a culture of continuous innovation by fostering collaborations with academic institutions, technology incubators, and policy think tanks. By aligning strategic roadmaps with the latest clinical research and regulatory developments, organizations will be well-positioned to set industry benchmarks, drive superior patient outcomes, and achieve sustainable growth in the competitive acute rehabilitation arena.

Detailing Rigorous Research Methodology Employed to Uncover Insights, Ensure Data Integrity and Validate Findings in Acute Rehabilitation Analysis

This analysis was underpinned by a robust research framework combining primary and secondary methodologies. Primary research involved in-depth interviews with senior executives, clinical directors, and rehabilitation specialists to gather qualitative perspectives on emerging challenges and innovation drivers. These insights were complemented by surveys of payers and provider organizations to gauge sentiment on reimbursement trends and technology adoption.

Secondary research entailed a comprehensive review of peer-reviewed journals, government health policy publications, and industry white papers to validate market dynamics and regulatory shifts. Data triangulation techniques were employed to reconcile disparate data points and ensure consistency across sources. Market mapping and competitive benchmarking exercises were conducted to position key players according to service offerings, geographic presence, and innovation portfolios.

All findings underwent validation through a rigorous review process, engaging subject matter experts in rehabilitation medicine, healthcare economics, and supply chain management. This iterative vetting ensured that conclusions reflect the latest industry standards, best practices, and anticipated policy developments. By integrating qualitative insights with quantitative analysis, the methodology provides a holistic view of the acute rehabilitation sector's trajectory and strategic imperatives.

Synthesizing Critical Conclusions That Highlight the Strategic Imperatives and Future Directions for Stakeholders in the Acute Rehabilitation Sector

The acute rehabilitation sector is at an inflection point, defined by converging technological advances, policy reforms, and shifting patient expectations. Organizations that can effectively integrate digital health solutions with personalized, multidisciplinary care models will elevate clinical outcomes and secure favorable reimbursement arrangements. Geographic and demographic segmentation offers pathways to tailor service portfolios, while regional nuances underscore the importance of adaptive strategies that align with local regulatory and economic contexts.

Navigating tariff impacts requires proactive supply chain strategies and a willingness to explore modular equipment designs and domestic partnerships. Market leaders will be those who anticipate these external pressures and respond with agile procurement and cost management initiatives. Collaboration across the value chain-from device innovators to clinical providers and payers-will catalyze the development of comprehensive rehabilitation ecosystems that support patients from acute stabilization through full community reintegration.

Ultimately, the imperatives for stakeholders center on innovation, resilience, and patient-centered excellence. By embracing data-driven decision-making, fostering strategic alliances, and continuously optimizing care pathways, organizations can seize opportunities for growth and differentiation. This summary provides the foundational insights necessary to chart a forward-looking strategy in the evolving acute rehabilitation landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2024
  • 3.5. FPNV Positioning Matrix, 2024
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Acute Rehabilitation Market, by Service Type

  • 8.1. Cardiac Rehabilitation
    • 8.1.1. Post Cardiac Surgery Therapy
    • 8.1.2. Post Heart Attack Rehabilitation
  • 8.2. Neurological Rehabilitation
    • 8.2.1. Stroke Rehabilitation
    • 8.2.2. Traumatic Brain Injury Rehabilitation
  • 8.3. Occupational Therapy
  • 8.4. Orthopedic Rehabilitation
  • 8.5. Physical Therapy
    • 8.5.1. Balance and Coordination Therapy
    • 8.5.2. Mobility Training
    • 8.5.3. Strength and Endurance Training
  • 8.6. Pulmonary Rehabilitation
  • 8.7. Speech & Language Therapy

9. Acute Rehabilitation Market, by Disease Type

  • 9.1. Abnormal Heart Rhythms
  • 9.2. Angina
  • 9.3. Atrial Fibrillation
  • 9.4. Cholesterol Management
  • 9.5. Coronary Artery Bypass Surgery
  • 9.6. Coronary or Peripheral Artery Disease
  • 9.7. Diabetes
  • 9.8. Heart Failure or Transplant
  • 9.9. High Blood Pressure
  • 9.10. Pulmonary Hypertension

10. Acute Rehabilitation Market, by Phase Type

  • 10.1. Phase I (Acute)
  • 10.2. Phase II (Sub-acute)
  • 10.3. Phase III (Long-term)
  • 10.4. Phase IV (Reintegration)

11. Acute Rehabilitation Market, by Device Type

  • 11.1. Cognitive/Speech Devices
  • 11.2. Mobility Devices
  • 11.3. Monitoring Tools
  • 11.4. Physio Equipment
  • 11.5. Robotic Devices

12. Acute Rehabilitation Market, by Patient Age Group

  • 12.1. Adults
  • 12.2. Geriatrics
  • 12.3. Pediatrics

13. Acute Rehabilitation Market, by Provider Type

  • 13.1. Home Based Rehabilitation
  • 13.2. Hospitals
  • 13.3. Inpatient Acute Rehabilitation Centers
  • 13.4. Outpatient Rehabilitation

14. Acute Rehabilitation Market, by End User

  • 14.1. Government & Public Health Agencies
  • 14.2. Healthcare Providers
  • 14.3. Patients

15. Acute Rehabilitation Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Acute Rehabilitation Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Acute Rehabilitation Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Acute Rehabilitation Market

19. China Acute Rehabilitation Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2024
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2024
  • 20.3. Product Portfolio Analysis, 2024
  • 20.4. Benchmarking Analysis, 2024
  • 20.5. Acadia Healthcare Company, Inc.
  • 20.6. Amedisys, Inc.
  • 20.7. Athena Health Care Systems
  • 20.8. Aurora Behavioral Health System
  • 20.9. Cambridge Medical and Rehabilitation Center
  • 20.10. CareOne Management, LLC by New Frontier Energy, Inc.
  • 20.11. ClearSky Health
  • 20.12. Covenant Care
  • 20.13. Ekso Bionics Holdings, Inc.
  • 20.14. Encompass Health Corporation
  • 20.15. Five Star Senior Living by AlerisLife Inc.
  • 20.16. Genesis Healthcare, Inc.
  • 20.17. HCA Healthcare, Inc.
  • 20.18. LHC Group, Inc. by UnitedHealth Group Incorporated
  • 20.19. LifePoint Health, Inc.
  • 20.20. National Healthcare Corporation
  • 20.21. Nexion Health, Inc.
  • 20.22. Oceans Healthcare
  • 20.23. Paradigm Healthcare
  • 20.24. Promises Behavioral Health, LLC
  • 20.25. Select Medical Corporation
  • 20.26. St. Ann's Community
  • 20.27. Tenet Healthcare Corporation
  • 20.28. The Alden Network
  • 20.29. The Ensign Group, Inc.
  • 20.30. Universal Health Services Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ACUTE REHABILITATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 2. GLOBAL ACUTE REHABILITATION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 3. GLOBAL ACUTE REHABILITATION MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 4. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ACUTE REHABILITATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 15. CHINA ACUTE REHABILITATION MARKET SIZE, 2018-2030 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ACUTE REHABILITATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 2. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 3. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 7. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY POST CARDIAC SURGERY THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY POST CARDIAC SURGERY THERAPY, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY POST CARDIAC SURGERY THERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY POST HEART ATTACK REHABILITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY POST HEART ATTACK REHABILITATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY POST HEART ATTACK REHABILITATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY STROKE REHABILITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY STROKE REHABILITATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY STROKE REHABILITATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY TRAUMATIC BRAIN INJURY REHABILITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY TRAUMATIC BRAIN INJURY REHABILITATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY TRAUMATIC BRAIN INJURY REHABILITATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY OCCUPATIONAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY OCCUPATIONAL THERAPY, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY OCCUPATIONAL THERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ORTHOPEDIC REHABILITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ORTHOPEDIC REHABILITATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ORTHOPEDIC REHABILITATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY BALANCE AND COORDINATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY BALANCE AND COORDINATION THERAPY, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY BALANCE AND COORDINATION THERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY MOBILITY TRAINING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY MOBILITY TRAINING, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY MOBILITY TRAINING, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY STRENGTH AND ENDURANCE TRAINING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY STRENGTH AND ENDURANCE TRAINING, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY STRENGTH AND ENDURANCE TRAINING, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PULMONARY REHABILITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PULMONARY REHABILITATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PULMONARY REHABILITATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY SPEECH & LANGUAGE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY SPEECH & LANGUAGE THERAPY, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY SPEECH & LANGUAGE THERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ABNORMAL HEART RHYTHMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ABNORMAL HEART RHYTHMS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ABNORMAL HEART RHYTHMS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ANGINA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ANGINA, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ANGINA, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ATRIAL FIBRILLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ATRIAL FIBRILLATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ATRIAL FIBRILLATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CHOLESTEROL MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CHOLESTEROL MANAGEMENT, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CHOLESTEROL MANAGEMENT, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CORONARY ARTERY BYPASS SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CORONARY ARTERY BYPASS SURGERY, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CORONARY ARTERY BYPASS SURGERY, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CORONARY OR PERIPHERAL ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CORONARY OR PERIPHERAL ARTERY DISEASE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CORONARY OR PERIPHERAL ARTERY DISEASE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 68. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DIABETES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 69. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DIABETES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 70. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HEART FAILURE OR TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 71. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HEART FAILURE OR TRANSPLANT, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 72. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HEART FAILURE OR TRANSPLANT, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 73. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HIGH BLOOD PRESSURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 74. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HIGH BLOOD PRESSURE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 75. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HIGH BLOOD PRESSURE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 76. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PULMONARY HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 77. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PULMONARY HYPERTENSION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 78. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PULMONARY HYPERTENSION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE I (ACUTE), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 81. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE I (ACUTE), BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 82. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE I (ACUTE), BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE II (SUB-ACUTE), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 84. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE II (SUB-ACUTE), BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 85. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE II (SUB-ACUTE), BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE III (LONG-TERM), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 87. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE III (LONG-TERM), BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 88. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE III (LONG-TERM), BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE IV (REINTEGRATION), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 90. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE IV (REINTEGRATION), BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 91. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE IV (REINTEGRATION), BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 92. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY COGNITIVE/SPEECH DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 94. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY COGNITIVE/SPEECH DEVICES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 95. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY COGNITIVE/SPEECH DEVICES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 96. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY MOBILITY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 97. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY MOBILITY DEVICES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 98. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY MOBILITY DEVICES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 99. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY MONITORING TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 100. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY MONITORING TOOLS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 101. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY MONITORING TOOLS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 102. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHYSIO EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 103. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHYSIO EQUIPMENT, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 104. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHYSIO EQUIPMENT, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ROBOTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 106. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ROBOTIC DEVICES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 107. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ROBOTIC DEVICES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 109. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 110. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ADULTS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 111. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 112. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 113. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY GERIATRICS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 114. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY GERIATRICS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 115. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 116. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 117. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 118. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HOME BASED REHABILITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 120. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HOME BASED REHABILITATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 121. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HOME BASED REHABILITATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 122. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 123. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 124. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 125. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY INPATIENT ACUTE REHABILITATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 126. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY INPATIENT ACUTE REHABILITATION CENTERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 127. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY INPATIENT ACUTE REHABILITATION CENTERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 128. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 129. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 130. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY GOVERNMENT & PUBLIC HEALTH AGENCIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 133. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY GOVERNMENT & PUBLIC HEALTH AGENCIES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 134. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY GOVERNMENT & PUBLIC HEALTH AGENCIES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 135. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 136. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HEALTHCARE PROVIDERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 137. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HEALTHCARE PROVIDERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 138. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PATIENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 139. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PATIENTS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 140. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PATIENTS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 141. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 142. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY SUBREGION, 2018-2030 (USD MILLION)
  • TABLE 143. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 145. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 146. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 147. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 151. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. NORTH AMERICA ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 154. NORTH AMERICA ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. NORTH AMERICA ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 156. NORTH AMERICA ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 157. NORTH AMERICA ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 158. NORTH AMERICA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. NORTH AMERICA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. NORTH AMERICA ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. NORTH AMERICA ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 162. NORTH AMERICA ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. NORTH AMERICA ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. LATIN AMERICA ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 165. LATIN AMERICA ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. LATIN AMERICA ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 167. LATIN AMERICA ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 168. LATIN AMERICA ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 169. LATIN AMERICA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. LATIN AMERICA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. LATIN AMERICA ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. LATIN AMERICA ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 173. LATIN AMERICA ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. LATIN AMERICA ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY SUBREGION, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. EUROPE ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 187. EUROPE ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. EUROPE ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 189. EUROPE ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 190. EUROPE ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 191. EUROPE ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. EUROPE ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. EUROPE ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. EUROPE ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 195. EUROPE ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. EUROPE ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. MIDDLE EAST ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 198. MIDDLE EAST ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. MIDDLE EAST ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 200. MIDDLE EAST ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 201. MIDDLE EAST ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 202. MIDDLE EAST ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. MIDDLE EAST ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. MIDDLE EAST ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. MIDDLE EAST ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 206. MIDDLE EAST ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. MIDDLE EAST ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 208. AFRICA ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 209. AFRICA ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. AFRICA ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 211. AFRICA ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 212. AFRICA ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 213. AFRICA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. AFRICA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. AFRICA ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. AFRICA ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 217. AFRICA ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. AFRICA ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 231. ASEAN ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 232. ASEAN ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. ASEAN ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 234. ASEAN ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 235. ASEAN ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 236. ASEAN ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. ASEAN ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. ASEAN ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. ASEAN ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 240. ASEAN ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. ASEAN ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 242. GCC ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 243. GCC ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. GCC ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 245. GCC ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 246. GCC ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 247. GCC ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. GCC ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. GCC ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. GCC ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 251. GCC ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. GCC ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. EUROPEAN UNION ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 254. EUROPEAN UNION ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. EUROPEAN UNION ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 256. EUROPEAN UNION ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 257. EUROPEAN UNION ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 258. EUROPEAN UNION ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. EUROPEAN UNION ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. EUROPEAN UNION ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. EUROPEAN UNION ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 262. EUROPEAN UNION ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. EUROPEAN UNION ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 264. BRICS ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 265. BRICS ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. BRICS ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 267. BRICS ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 268. BRICS ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 269. BRICS ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. BRICS ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. BRICS ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. BRICS ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 273. BRICS ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. BRICS ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 275. G7 ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 276. G7 ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. G7 ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 278. G7 ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 279. G7 ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 280. G7 ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. G7 ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. G7 ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. G7 ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 284. G7 ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. G7 ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 286. NATO ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 287. NATO ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. NATO ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 289. NATO ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 290. NATO ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 291. NATO ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 292. NATO ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 293. NATO ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. NATO ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 295. NATO ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 296. NATO ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 297. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 298. UNITED STATES ACUTE REHABILITATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 299. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 300. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 301. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 302. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 303. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 304. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 305. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 306. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 307. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
  • TABLE 308. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 309. CHINA ACUTE REHABILITATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 310. CHINA ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 311. CHINA ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 312. CHINA ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 313. CHINA ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 314. CHINA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 315. CHINA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 316. CHINA ACUTE RE